FLF hosts first International Summit in Tel Aviv
The Follicular Lymphoma Foundation (FLF) proudly hosted its first international FL Summit, titled “Joining Forces to Cure Follicular Lymphoma,” in Tel Aviv, Israel. The summit, held in January 2023, exceeded all expectations and marked a major milestone for the FLF. The summit brought together a diverse group of lymphoma experts, scientists, researchers, and representatives from […]
ASH Annual Meeting 2022 – Research and insight summary
ASH Annual Meeting 2022 – summary and key take-outs By Dr Zoe Drymoussi During the 9-12th December 2022, the FLF team attended, in person, for the biggest events of the year in the world of haematology – the American Society of Hematology (ASH) annual meeting. More than 25,000 delegates, showcasing 3000+ abstracts, took over the […]
Looking back over the last 25 years for FL – the Rituximab era
Looking back over the last 25 years for FL – the Rituximab era By Dr Mitchell Smith, Chief Medical Officer A recent re-publication marking 25 years since the seminal 1998 Journal of Clinical Oncology paper (1) upon which Rituximab was approved for relapsed/refractory follicular or low-grade lymphoma (1997 by U.S. FDA, and 1998 by European […]
The FLF’s Precision Medicine Programme research goals
The FLF’s Precision Medicine Programme Research Goals Technical abstract: The FLF undertook extensive landscaping and scoping work, identifying a substantial set of unmet needs in follicular lymphoma that the Precision Medicine Programme (PMP) could help to address. This could significantly push the field forward for FL. Several unmet needs remain unresolved: Improve understanding of the […]
Research in focus: Bi-specific antibodies approval.
Research in focus: Bi-specific antibodies approval. By Dr. Zoe Drymoussi Over the last few years, a promising new class of treatments for advanced-stage FL has been in development, with mosunetuzumab being the first in this class to be approved in Europe (by the EMA; European Medicines Agency) and likely to receive U.S. FDA (Federal Drug […]
FLF are attending the ASH 2022 Annual Meeting
FLF are attending the ASH 2022 Annual Meeting We are delighted that some of the team are able to attend the 64th ASH Annual Meeting and Exposition, in New Orleans Louisiana, USA from the 10th to the 13th December 2022. The FLF team will be attending sessions, building relationships, and most importantly sharing our latest […]
CURE FL Awards. Funding $2m of targeted, innovative, patient driven research
New funding of $2 million for research to get one step closer to a cure for Follicular Lymphoma. Our mission at the FLF is to lead new and determined efforts to find innovative treatments and cures for Follicular Lymphoma (FL). In pursuit of this, the CURE FL Awards grant programme seeks to catalyse scientific research […]
A big thank-you to all at Henry and Esther’s Golden Anniversary celebration
Henry and Esther Shirman, two supporters that have been with the FLF since day one, recently celebrated their 50th wedding anniversary, and they certainly did so in style! Fifty years on, they decided to recreate a special photo from their wedding day – with Esther even wearing her actual wedding dress. With the pair dressed […]
The fabulous kindness of the Snowdown Colliery Welfare Brass Band
The wonderful Snowdown Colliery Welfare Brass Band recently (October 8th) created a fabulous afternoon of music for the local community of Dover, Kent. The band played music chosen by one of the band members who has been diagnosed with FL and is currently in remission. The band aimed to raise funds for FLF and also […]
Kate Rogers our new CEO
Kate Rogers joins from her previous role at GSK plc as Global Finance Transformation Lead at GSK. She also continues to serves as Non-Executive Director and Audit Committee Chair for Ixico Plc, a Medical Imaging company for Biopharmaceutical clinical research. Previous to leading the recent transformation, Kate was CFO for Laboratoire Glaxo SmithKline SaS (GSK […]